Login / Signup

Advances in the pharmacological and regulatory management of multidrug resistant Helicobacter pylori .

Theodore RokkasKonstantinos Ekmektzoglou
Published in: Expert review of clinical pharmacology (2023)
strains should follow the principles of antibiotic stewardship, i.e. eradication regimens should be optimized with regard to all aspects of therapy, including drugs, doses, formulation, frequency of administration, administration in relation to meals and duration of therapy that reliably achieve at least 90% (preferably >95%) cure rates in adherent patients with susceptible infections.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • multidrug resistant
  • escherichia coli
  • drug delivery
  • stem cells
  • acinetobacter baumannii
  • pseudomonas aeruginosa
  • cystic fibrosis
  • gram negative
  • replacement therapy